Name | 4-[2-(3-nitrophenoxy)ethyl]morpholine |
---|---|
Synonyms |
3-[2-(N-Morpholino)ethoxy]-1-nitrobenzene
4-[2-(3-nitro-phenoxy)-ethyl]-morpholine |
Molecular Formula | C12H16N2O4 |
---|---|
Molecular Weight | 252.26600 |
Exact Mass | 252.11100 |
PSA | 67.52000 |
LogP | 1.76690 |
Risk Phrases | R20/21/22-34 |
---|---|
Safety Phrases | S26 |
RIDADR | UN 3261 |
~96% 182618-90-2 |
Literature: RIGEL PHARMACEUTICALS, INC. Patent: WO2007/30680 A2, 2007 ; Location in patent: Page/Page column 152 ; WO 2007/030680 A2 |
~% 182618-90-2 |
Literature: Merck Sharp and Dohme Ltd. Patent: US5556969 A1, 1996 ; US 5556969 A |
Precursor 4 | |
---|---|
DownStream 1 | |